Global diagnostics reach Euroimmun operates in over 140 countries with a broad line of medical laboratory diagnostics, software, and automation solutions. This presents a sales opportunity to expand partnerships with labs, hospitals, and health authorities across regions currently served by distributors or requiring broader test menus.

Tcell assay expansion Recent launch of SARS-CoV-2 Interferon Gamma Release Assay for research use highlights expertise in immunoassays and immune monitoring. There is potential to cross-sell related autoimmune and infectious disease test systems and companion software for T-cell and immune response diagnostics.

Diverse customer base Products target laboratories, hospitals, health authorities, and academia in autoimmune, infectious, allergy, and genetic disease testing. This breadth enables tailoring of bundled solutions consisting of test kits, software analytics, and automation to fit specific institutional workflows.

Digital and automation focus Stack includes NetSuite, analytics, Kubernetes, and automation software. Opportunities exist to position Euroimmun as a partner for lab digitalization, AIOps for diagnostics workflows, data integration, and scalable automation to reduce turnaround times and labor costs.

Revenue scale and partnerships With mid-market revenue and competitors of similar size, Euroimmun can pursue channel partnerships and OEM or co-development deals with larger players in the diagnostics ecosystem to accelerate market access and co-create higher-value test platforms.